# Alan raises €480M led by Prosus at a €5.5bn valuation > Source: > Published: 2026-06-25 14:49:53+00:00 *French insurtech Alan has raised €480M led by Prosus at a €5.5bn valuation, just months after its last round. The Paris company is betting that AI-driven prevention can reshape health insurance.* Alan, the French health insurance company, has [raised €480m](https://www.prnewswire.com/news-releases/alan-announces-a-480-million-financing-round-to-make-prevention-insurance-the-new-global-standard-in-healthcare-302809870.html) ($550m). The deal values the Paris firm at €5.5bn ($6.3bn). Dutch investor Prosus led the round, in one of Europe’s largest non-AI raises of the year. The financing is a Series G. Existing backers Teachers’ Venture Growth and Index Ventures joined, alongside new investor Dara Holdings. The round still needs regulatory sign-off, including from France’s financial authorities. Insurers do not close rounds the way pure software firms do. The pace is what stands out. Alan raised €100m at a [€5bn valuation](https://thenextweb.com/news/alan-health-insurance-5-billion-valuation) just three months earlier. This round lifts that figure by €500m and pushes its total funding past €1.2bn. Few European startups raise twice in a single quarter. ## The prevention pitch Alan calls its model “prevention insurance.” It bundles health cover, care navigation, wellbeing services and AI health assistance into a single app. The idea is to act before illness, not after it. Founded in 2016 by Jean-Charles Samuelian-Werve and Charles Gorintin, the company argues that healthcare is built to wait. It waits for a six-month appointment, for symptoms to worsen, for cover that only kicks in once you are sick. Alan wants to flip that order. “Health can’t wait, not for symptoms to get worse, not for a six-month appointment, not for the system to catch up,” said Samuelian-Werve, the co-founder and chief executive. “We believe great health is a universal right, and that prevention should be too.” For ten years, the company has pushed the same line: technology can make care proactive rather than reactive. It began as a digital health insurer and added services on top. The prevention insurance label is its attempt to name that whole bundle as a category, not just a slicker policy. In practice, members get reimbursements known for their speed, doctors they can reach through the app, and support seven days a week. Alan is regulated by France’s ACPR, the country’s prudential supervisor, and works as an independent insurer rather than a broker. ## The numbers behind the raise Alan enters this round from a strong base. In the first quarter of 2026 it passed €800m in annual recurring revenue and grew 53% year on year. It now serves more than 1.1 million members, and it is profitable in France. That last point matters. Many insurtechs burn cash for years, and steady profit is rare in the category. Alan also operates in Spain, Belgium and Canada, counts more than 37,000 businesses as clients, and employs over 850 people. Member satisfaction sits above 4.2 out of 5. The customer mix is broad. Beyond those 37,000 businesses, Alan covers self-employed professionals and retirees, groups traditional insurers often treat as afterthoughts. That spread gives it data across age and income, the raw material its AI tools need to spot risk early. The model is capital-hungry by design. Insurance demands reserves, and expansion into new markets demands more. A profitable home market gives Alan a cushion that pure-growth rivals lack. ## Why Prosus The lead investor is telling. Prosus is the investment arm of South Africa’s Naspers, best known for its giant Tencent stake. It has spent years buying consumer platforms, including the €4.1bn purchase of [Just Eat Takeaway](https://thenextweb.com/news/prosus-acquires-just-eat-takeaway) and the $1.8bn deal for Stack Overflow. That track record is the point. Prosus brings a global network and deep experience in scaling consumer products, the kind of muscle Alan needs to push beyond France. “Healthcare presents one of the most significant global opportunities for AI-led transformation,” said Fahd Beg, head of investments at Prosus Group. He praised Alan’s “integrated platform where insurance, prevention and care delivery reinforce each other.” Prosus is also building AI tools across that empire. It recently launched ToqanClaw, an agent builder aimed at the roughly five million merchants in its network. Plugging Alan into that ecosystem could hand the insurer ready-made distribution in markets where it has no brand. ## The AI bet Artificial intelligence sits at the centre of the plan. Alan believes AI can make personalised prevention, navigation and support available to everyone, not just the wealthy. Paired with its insurance platform, it hopes to improve outcomes while trimming the long-term cost of care. The thesis is not Alan’s alone. A wider European push is reframing healthcare around early detection rather than late treatment. Neko Health, the body-scanning startup from Spotify’s Daniel Ek, has raised tens of millions for its own take on [preventive healthcare](https://thenextweb.com/news/spotify-ceo-ai-powered-preventive-healthcare-startup-raises-60m). The bet across the sector is that prevention pays. It remains a bet. Insurers have promised to reward healthy behaviour for years, with mixed results. Turning app nudges and AI assistants into measurably better health, at scale, is the hard part Alan still has to prove. ## A bright spot for French tech The timing is kind. French startup funding fell 5% in 2025, and [France’s startup scene](https://thenextweb.com/news/frances-startup-scene-is-falling-behind-the-us-and-europe-and-ai-is-both-the-cause-and-the-cure) has been losing ground to the US. A €480m round is a rare piece of good news. The gap with the US is the wider backdrop. European startups raised barely a third of what their American peers did last year, and large late-stage cheques remain scarce on the continent. A €480m round for a profitable, decade-old company is exactly the kind of deal Europe has struggled to produce. Alan now joins a short list of French companies raising at scale, alongside names like fintech [Pennylane](https://thenextweb.com/news/french-fintech-pennylane-europes-latest-unicorn). The capital will fund new countries, deeper roots in France, Belgium, Spain and Canada, fresh acquisitions, and heavy spending on AI and health services. The ambition is large. Alan wants prevention insurance to become a global standard, not a French niche. Prosus has bet €480m that it can. Whether that category travels, or stays a well-funded experiment at home, is the question this round leaves open. ## Get the TNW newsletter Get the most important tech news in your inbox each week.